A paradigm for Africa-centric vaccine development in Equatorial Guinea.
Trends Parasitol
; 40(5): 362-366, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38582683
ABSTRACT
The Equatorial Guinea Malaria Vaccine Initiative (EGMVI) highlights how long-term African government and international energy industry investment, plus novel partnerships, can enable clinical development of vaccines in Africa, for Africa. We review achievements and challenges of this pioneering, award-winning, public-private partnership which offers a model for future Africa-centric clinical research and development (R&D).
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Vacunas contra la Malaria
/
Desarrollo de Vacunas
Límite:
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
Trends Parasitol
Asunto de la revista:
PARASITOLOGIA
Año:
2024
Tipo del documento:
Article